This inventor holds 1 USPTO granted patent. Top assignee: Tap Pharmaceuticals, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Anthony Killian
Introduction
Anthony Killian is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of medical science, particularly in the treatment of preeclampsia. His innovative approach has the potential to improve the health outcomes of pregnant women facing this serious condition.
Latest Patents
Anthony Killian holds a patent for a method of treating preeclampsia. The patent describes the use of straight-chain alkanoic acids, which are substituted at the .OMEGA.-carbon atom by a substituted phenyl, naphthyl, furyl, or thienyl group, along with a substituted 1,4-benzoquinon-2-yl group. This method is effective in the therapy or prophylaxis of conditions associated with lipid peroxide injury to vascular endothelium, particularly preeclampsia and eclampsia in pregnant females. He has 1 patent to his name.
Career Highlights
Anthony Killian is currently associated with Tap Pharmaceuticals, Inc. His work at the company focuses on developing innovative solutions for medical challenges, particularly those affecting women's health. His dedication to research and development has positioned him as a valuable asset in the pharmaceutical industry.
Conclusion
Anthony Killian's contributions to the field of medicine through his innovative patent for treating preeclampsia highlight his commitment to improving healthcare for pregnant women. His work exemplifies the impact that dedicated inventors can have on society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile